Evidence method
Level · gp.fundamentals.capex_revenue_ratio
10.07% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
DXCM · Mar 31, 2023
DEXCOM INC. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001093557-23-000118General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
20.96% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
17.92% · CORE · VALID
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
49.36% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
62.39% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
6.37% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
16.05% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
4.75% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History21 statesSelf-history eligible
Mar 31, 20190/7 normalizedLevel 3Jun 30, 20190/7 normalizedLevel 3Sep 30, 20190/7 normalizedLevel 3Dec 31, 20190/8 normalizedLevel 3Mar 31, 20200/8 normalizedLevel 3Jun 30, 20200/8 normalizedLevel 3Sep 30, 20200/8 normalizedLevel 3Dec 31, 20207/8 normalizedLevel 3Mar 31, 20217/8 normalizedLevel 3Jun 30, 20217/8 normalizedLevel 3Sep 30, 20217/8 normalizedLevel 3Dec 31, 20218/8 normalizedLevel 3Mar 31, 20228/8 normalizedLevel 3Jun 30, 20228/8 normalizedLevel 3Sep 30, 20228/8 normalizedLevel 3Dec 31, 20228/8 normalizedLevel 3Mar 31, 20238/8 normalizedLevel 3Jun 30, 20238/8 normalizedLevel 3Sep 30, 20238/8 normalizedLevel 3Sep 30, 20268/8 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- 12.54%
- Current
- 10.07%
- Delta
- -2.46%
- Previous
- 23.01%
- Current
- 20.96%
- Delta
- -2.05%
- Previous
- 18.84%
- Current
- 17.92%
- Delta
- -0.92%
- Previous
- 10.54%
- Current
- 49.36%
- Delta
- 38.82%
- Previous
- 64.72%
- Current
- 62.39%
- Delta
- -2.33%
- Previous
- 13.44%
- Current
- 6.37%
- Delta
- -7.08%
- Previous
- 16.64%
- Current
- 16.05%
- Delta
- -0.59%
- Previous
- 4.35%
- Current
- 4.75%
- Delta
- 0.40%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · DXCM Fundamental State →Has State · DEXCOM INC →Transitioned To · DXCM Fundamental State →Transitioned To · DXCM CAPEX_INTENSITY_DECREASED →Transitioned To · DXCM CASH_GENERATION_DECREASED →Transitioned To · DXCM GROWTH_DECREASED →Transitioned To · DXCM INVENTORY_PRESSURE_INCREASED →Transitioned To · DXCM MARGIN_DECREASED →Transitioned To · DXCM PROFITABILITY_DECREASED →Transitioned To · DXCM R_AND_D_INTENSITY_DECREASED →Transitioned To · DXCM SBC_INTENSITY_INCREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.